Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Suresh C Varma
Panitumumab Added to Docetaxel, Cisplatin and Fluoropyrimidine in Oesophagogastric Cancer: ATTAX3 Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Related publications
Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase I Trial of Docetaxel, Cisplatin and Concurrent Radical Radiotherapy in Locally Advanced Oesophageal Cancer
British Journal of Cancer
Cancer Research
Oncology
Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Phase I Trial of Concomitant Hyperfractionated Radiotherapy With Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer
Cancer Journal
Cancer Research
Oncology
A Phase II Trial of Ixabepilone in Asian Patients With Advanced Gastric Cancer Previously Treated With Fluoropyrimidine-Based Chemotherapy
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Safety and Efficacy of Docetaxel Plus Cisplatin Versus Cisplatin Concurrent With Radiation in Local Advanced Cervical Cancer: Midterm Results of a Phase III, Multicenter and Randomized Trial
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma
Urology
Urology
Phase I Trial of Vorinostat Added to Chemoradiation With Capecitabine in Pancreatic Cancer
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
